Whilst there are many candidates currently undergoing investigation for a workable vaccine or drug against COVID-19, they are all still in the very early phases of development and being used in an ‘unlicensed fashion’ within clinical trials being conducted worldwide.

COVID-19, like several infectious diseases is extremely challenging to deal with especially given its high rate of transmissibility. Viruses in particular present a major challenge to scientists in developing a cure as they often mutate. The flu virus is a typical example as there are 4 types of the virus which are referred to as
Continue Reading…